Results 231 to 240 of about 377,702 (260)
Some of the next articles are maybe not open access.

The oncogenicity of avian adenoviruses I. An unusually large number of viral DNA molecules in some tumors, and virus-specific T-antigenic proteins

Virology, 1980
Abstract Subcutaneous tumors were produced in hamsters injected with a well-known oncogenic serotype (CELO virus) of avian adenovirus, and with each of four new serotypes. All eight of the CELO virus-induced hamster tumors and two CELO virus-transformed rat cell lines carried the viral DNA.
M, Ishibashi   +3 more
openaire   +2 more sources

Mechanism of transcriptional activation of viral and cellular genes by oncogenic protein of HTLV-1.

Leukemia, 1994
Regulatory protein Tax of human T cell leukemia virus type 1 (HTLV-1) positively regulates the transcription of its own genome and specific cellular genes, and contributes to the pathogenicity in ATL, HAM/TSP and other associated diseases. The one mechanism of the transcriptional activation includes binding of Tax protein in nucleus to enhancer binding
openaire   +1 more source

Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.

Oncogene research, 1989
The cellular transformation induced by viral tyrosine protein kinases may result from the excessive phosphorylation of the normal polypeptide substrates of endogenous cellular tyrosine kinases, from the phosphorylation of proteins that are not normal substrates of cellular tyrosine protein kinases in uninfected cells, or from the phosphorylation of ...
M P, Kamps, B M, Sefton
openaire   +1 more source

Immunoinformatics‐Driven Design of a Multi‐Epitope Vaccine Targeting Simian Virus VP1 Major Capsid Protein for Oncogenic Viral Infection Prevention

Reviews in Medical Virology
ABSTRACT Simian Virus (SV) 40 is a DNA virus that remains dormant in the body but occasionally induces tumours in animals. Evidence indicates that SV40 could be crucial in developing certain human cancers. There is no commercial vaccine available against SV40.
Roman Akbar   +7 more
openaire   +2 more sources

Early Cellular Responses to the Activation of a Mitogenic/Oncogenic Viral K‐RAS Protein

Annals of the New York Academy of Sciences, 1988
Durkin, J.   +6 more
openaire   +3 more sources

Prevention of apoptosis in CNTF-dependent neurons by a mutant ICE and by viral protein CrmA but not by proto-oncogene product Bcl-2.

Cell death and differentiation, 2012
The interleukin-1beta converting enzyme (ICE) gene family, (homologues of C. elegans cell death gene product Ced-3) plays an important role in controlling programmed cell death. Nerve growth factor (NGF) promotes survival of cultured embryonic chicken dorsal root ganglion neurons.
W, Li, M C, Fishman, J, Yuan
openaire   +1 more source

Host microRNA-31-5p represses oncogenic herpesvirus lytic reactivation by restricting the RNA-binding protein KHDRBS3-mediated viral gene expression

Abstract Oncogenic Kaposi’s sarcoma-associated herpesvirus (KSHV), an etiological agent of Kaposi’s sarcoma and primary effusion lymphoma, employs a biphasic life cycle consisting of latency and lytic replication to achieve lifelong infection.
Soo Mi Lee   +6 more
openaire   +2 more sources

THE KSHV/HHV 8 G PROTEIN COUPLED RECEPTOR IS A VIRAL ONCOGENE AND ANGIOGENESIS ACTIVATOR

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 1998
Carlos Bais   +9 more
openaire   +1 more source

Home - About - Disclaimer - Privacy